Location: San Antonio, Texas
Associate Director, Parisa Valadan is delighted to be representing Purdie Pascoe at SABCS 2025.
Is your team involved in breast cancer precision medicine or diagnostics?
Are you working on the next big treatment in breast oncology?
Are you offering patients innovative approaches to breast cancer treatment and support?
Are your tests helping to facilitate the treatment continuum?
If patient well-being and successful outcomes are at the core of what you do, then let’s connect. Meet Parisa Valadan, Associate Director at SABCS 2025!
Why connect with us at the conference?
Our Precision Medicine and Diagnostics team has extensive experience conducting primary market research in the breast cancer space. We bring together scientific rigor and commercial insight to help teams:
Understand real-world diagnostic journeys (e.g. patients research online communities)
Identify barriers and drivers of diagnostic adoption (e.g. why are some biomarkers under-utilized and how to fix it)
Strengthen pre- and post-launch strategies (e.g. how to ensure that testing strategies are optimal, or that new panels are competitive from the onset)
Build a holistic, evidence-driven view of the competitive landscape (e.g. how is my brand and my competitors’ brands perceived, and how can we shift the needle)
Let’s connect in San Antonio
Whether you’d like to schedule a meeting or simply grab a coffee, Parisa will be delighted to connect during the conference.
Not attending SABCS this year?
We’d still welcome the opportunity to discuss your 2026 research plans and explore how we can support your upcoming market research needs. Please reach out to Marianne Fillion, Head of Precision Medicine and Diagnostics and Parisa Valadan, Associate Director to arrange a virtual call.